Compare Amylx Pharmaceuticals Inc (AMLX) vs Ferrari NV (RACE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs Ferrari NV — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Ferrari NV trades at $406 (market cap $71.67B). The key difference: Ferrari NV is far larger — about 27.1× Amylx Pharmaceuticals Inc's market cap, and Ferrari NV pays a 1.04% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | RACE | |
|---|---|---|
Market Cap | $2.64B | $71.67B |
Sector | Health | Consumer Cyclical |
52-Week High | $24.19 | $504.09 |
52-Week Low | $7.82 | $314.63 |
Enterprise Value | $2.39B | $73.60B |
Dividend Yield | — | 1.04% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About Ferrari NV
Ferrari engineers and manufactures some of the world's most expensive exotic sports cars. The Ferrari brand is synonymous with Formula One racing, exclusivity, Italian design, and state-of-the-art technology. Ferrari also has a captive finance company that provides funding for dealers and clients.
Read more on RACE →
